explore -WSS

explore

author：fashion 2025-10-01 11:46:40 - browse：83

Astrazeneca office building -- health policy coverage from STAT — AstraZeneca is suing the Biden administration to stop a new Medicare drug price negotiation program. Adobe

WASHINGTON — AstraZeneca is the sixth drugmaker to pile on a legal challenge to the Biden administration’s drug pricing reform law.

The Medicare drug price negotiation program created in the Inflation Reduction Act is set to kick off in the next week, as officials will release the names of the first 10 medicines that will be selected for the program. Medicines are eligible for selection if they are one of the highest-spend drugs for Medicare, and they have no generic competition.

AstraZeneca makes drugs that could be selected for the list, and asked a Delaware district court judge to rule that Medicare acted illegally and that the law is unconstitutional.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： UpToDate has a racism problem: Dr. Stanley Goldfarb

hotspot

WSS

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

White House finalizes ITC's import ban of latest Apple Watches

A single drug, study failures leave Anavex with nothing but cash

Burning questions for the 2024 JPM Healthcare Conference

3 trends to watch in health tech's hiring outlook for 2024

How a scoliosis diagnosis changed the life of one young dancer

focus

explore

focus

Alkermes shareholders re

Being 'nonadherent' patient made me a more empathetic doctor

As demand for Covid shots wanes, Moderna seeks its next success

New weight loss drugs work. But how can they best be used?

How to save PrEP access — and even expand it

Being 'nonadherent' patient made me a more empathetic doctor

Activists slam private health insurers over coverage restrictions

New weight loss drugs work. But how can they best be used?

Cancer drug shortages should be causing more outrage

How Robert F. Kennedy Jr. distorted vaccine science

hotspot

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

Burning questions for the 2024 JPM Healthcare Conference

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

New weight loss drugs work. But how can they best be used?

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Canadians with cystic fibrosis outlive Americans by a decade

focus

hotspot

explore

Wikipedia